Jaguar Health (JAGX) Return on Capital Employed (2015 - 2026)
Jaguar Health (JAGX) reported Return on Capital Employed of 936.95% for Q1 2026, up 106915.0% year-over-year from N/an in Q1 2025, and up 166.2% quarter-over-quarter from 1415.38% in Q4 2025.
Jaguar Health (JAGX) Return on Capital Employed (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 12 years of Return on Capital Employed data on file, last reported at 936.95% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 936.95%, up 106915.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 936.95% (up 106915.0% YoY), and the FY2025 annual result was 879.46%, down 78428.0% from the prior year.
- Return on Capital Employed rose to 936.95% in Q1 2026 per JAGX's latest filing, from 1415.38% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 936.95% in Q1 2026 and troughed at 1415.38% in Q4 2025.
- A 5-year average of 144.11% and a median of 132.2% in 2025 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2025 and 2026: Return on Capital Employed sank 133031 bps in 2025, then surged 106915 bps in 2026.
- A 5-year view of Return on Capital Employed shows it stood at 180.84% in 2022, then surged by 44 bps to 100.61% in 2023, then advanced by 15 bps to 85.07% in 2024, then slumped by 1564 bps to 1415.38% in 2025, then soared by 166 bps to 936.95% in 2026.
- Business Quant data shows JAGX's Return on Capital Employed at 936.95% in Q1 2026, 1415.38% in Q4 2025, and 257.48% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 450.31% |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 51.73% |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -107.40% |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -50.43% |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | 936.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 936.95% |
| Dec 31, 2025 | -1,415.38% |
| Sep 30, 2025 | -257.48% |
| Jun 30, 2025 | -159.10% |
| Mar 31, 2025 | -132.20% |
| Dec 31, 2024 | -85.07% |
| Sep 30, 2024 | -75.41% |
| Jun 30, 2024 | -80.82% |
| Mar 31, 2024 | -92.62% |
| Dec 31, 2023 | -100.61% |
| Sep 30, 2023 | -90.91% |
| Jun 30, 2023 | -133.60% |
| Mar 31, 2023 | -154.10% |
| Dec 31, 2022 | -180.84% |
| Sep 30, 2022 | -164.75% |
| Jun 30, 2022 | -135.41% |
| Mar 31, 2022 | -128.51% |
| Dec 31, 2021 | -99.77% |
| Sep 30, 2021 | -66.82% |
| Jun 30, 2021 | -54.69% |